Combined drug Approach to Prevent Ischemia-reperfusion injury during Transplantation of Livers (CAPITL): a first-in-men study
Latest Information Update: 22 Jun 2021
At a glance
- Drugs Antithrombin III (Primary) ; Complement C1 inhibitor protein (Primary) ; Epoetin beta (Primary) ; Epoprostenol (Primary) ; Glutathione (Primary) ; Infliximab (Primary) ; Melatonin (Primary) ; Transferrin receptor modulators (Primary) ; Vitamin E (Primary)
- Indications Reperfusion injury
- Focus First in man; Pharmacodynamics
- Acronyms CAPITL study
- 22 Jun 2021 New trial record